Healthcare & Life Sciences
Re-Aim Therapeutics
Re-Aim Therapeutics is a Healthcare & Life Sciences startup, most recent round Seed, 1 tracked investor.
seed
seed
Stage
1
Investors
About Re-Aim Therapeutics
Re-Aim Therapeutics is a startup. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Re-Aim Therapeutics is listed in Syncona's portfolio as a pre-clinical therapeutics company. It is a biotechnology firm focused on developing therapeutic candidates (pre-clinical stage).
Explore Re-Aim Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.